CHAPAS-4 trial shows benefit of new antiretroviral combinations for second-line treatment of children living with HIV
Our HIV research at the International AIDS Society 2023 Conference on HIV Science
New podcast episode: The REFINE trial: how can we improve the way we give cancer immunotherapy?
UK-based tuberculosis treatment trial recruits first participant
Which people with metastatic prostate cancer benefit most from upfront docetaxel?